Screener
Arcus Biosciences RCUS Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Arcus Biosciences’s reported figures.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's invested capital?
- Arcus Biosciences (RCUS) reported invested capital of $428M in Q2 2026.
- How has Arcus Biosciences's invested capital changed year-over-year?
- Arcus Biosciences's invested capital increased by 4.4% year-over-year, from $410M to $428M.
- What is the long-term trend for Arcus Biosciences's invested capital?
- Over 5 years (2020 to 2025), Arcus Biosciences's invested capital has grown at a 11.9% compound annual growth rate (CAGR), from $346.7M to $607M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Arcus Biosciences's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude